Approval · Notice of Compliance 17447 · 2015
ANAPROX: Notice of Compliance 17447
Issued November 4, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17447
- Date
- November 4, 2015
- Company
- Atnahs Pharma Uk LimitedBasildon, Essex, United Kingdom
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification numbers
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ANAPROX | 02162725 | Marketed |
| ANAPROX DS | 02162717 | Marketed |
Medicinal ingredients
- NAPROXEN SODIUM 275 MG per TAB
- NAPROXEN SODIUM 550 MG per TAB